Select products/medications of interest
AOD-9604 growth hormone fragment — targets fat metabolism and lipolysis without affecting blood sugar or IGF-1.
GLP-3R (Retatrutide) triple receptor agonist — next-generation metabolic and weight loss compound.
GLP-1 (Semaglutide) weight loss program — clinically supervised evaluation and treatment.
GLP-2T (Tirzepatide) dual agonist weight loss program — clinically supervised evaluation.